Related Experiment Video
Updated: May 4, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability
Feng Yang1, Xuchao Xue, Luming Zheng
1Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Long non-coding RNAs (lncRNAs), a recently characterized class of non-coding RNAs, have been shown to have important regulatory roles and are de-regulated in a variety of tumors. However, the contributions of lncRNAs to gastric carcinoma and their functional mechanisms remain largely unknown. In this study, we found that lncRNA gastric carcinoma high expressed transcript 1 (lncRNA-GHET1) was up-regulated in gastric carcinoma. The over-expression of this lncRNA correlates with tumor size, tumor invasion and poor survival. Gain-of-function and loss-of-function analyses demonstrated that GHET1 over-expression promotes the proliferation of gastric carcinoma cells in vitro and in vivo. Knockdown of GHET1 inhibits the proliferation of gastric carcinoma cells. RNA pull-down and immunoprecipitation assays confirmed that GHET1 physically associates with insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) and enhances the physical interaction between c-Myc mRNA and IGF2BP1, consequently increasing the stability of c-Myc mRNA and expression. The expression of GHET1 and c-Myc is strongly correlated in gastric carcinoma tissues. Depletion of c-Myc abolishes the effects of GHET1 on proliferation of gastric carcinoma cells. Taken together, these findings indicate that GHET1 plays a pivotal role in gastric carcinoma cell proliferation via increasing c-Myc mRNA stability and expression, which suggests potential use of GHET1 for the prognosis and treatment of gastric carcinoma.
Insights
Long non-coding RNA GHET1 promotes gastric cancer growth by stabilizing c-Myc. This finding suggests GHET1 as a potential target for gastric carcinoma treatment and prognosis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are regulatory molecules implicated in various cancers.
- The specific roles of lncRNAs in gastric carcinoma remain largely undefined.
Purpose of the Study:
- To investigate the role of lncRNA-GHET1 in gastric carcinoma.
- To elucidate the functional mechanisms underlying GHET1's involvement in gastric cancer progression.
Main Methods:
- Quantitative analysis of lncRNA-GHET1 expression in gastric carcinoma tissues.
- In vitro and in vivo gain- and loss-of-function experiments.
- RNA pull-down, immunoprecipitation, and correlation analyses to identify molecular interactions.
Main Results:
- lncRNA-GHET1 is upregulated in gastric carcinoma and correlates with tumor size, invasion, and poor survival.
- GHET1 overexpression promotes gastric carcinoma cell proliferation, while its knockdown inhibits it.
- GHET1 binds to IGF2BP1, enhancing c-Myc mRNA stability and expression, which drives proliferation.
Conclusions:
- lncRNA-GHET1 promotes gastric carcinoma cell proliferation by stabilizing c-Myc mRNA.
- GHET1 represents a potential prognostic biomarker and therapeutic target for gastric carcinoma.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
lncRNA - Long Non-coding RNAs
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: